Clarivate Epidemiology's coverage of Crohn's disease (CD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…
Clarivate Epidemiology’s coverage of ulcerative colitis (UC) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence…
Clarivate’s extended worldwide coverage is the first and only evidence-based data set of epidemiological forecasts for key ovarian cancer patient populations covering 171 countries and more than…
Clarivate Epidemiology's coverage of ovarian cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key Crohn’s disease patient populations covering 171 countries and…
Clarivate Epidemiology's coverage of Crohn's disease comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of…
Clarivate Epidemiology’s coverage of ulcerative colitis (UC) comprises epidemiological estimates of key patient populations in both mature (the United States, France, Germany, Italy, Spain, the…
Clarivate Epidemiology's coverage of Crohn's disease comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
Clarivate Epidemiology's coverage of Crohn's disease comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key ulcerative colitis patient populations covering 171 countries and…
Clarivate Epidemiology's coverage of Crohn's disease comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
Clarivate Epidemiology's coverage of Crohn's disease comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
The urticaria drug market is dominated by oral medications, including second-generation, nondrowsy antihistamines, prescribed for both chronic inducible and chronic spontaneous urticaria. However,…
DRG’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key dermatitis patient populations covering 171 countries and more than 99%…
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key AD patient populations covering 171 countries and more than 99% of…